Company Overview of Boston University School of Medicine
715 Albany Street
Boston, MA 02118
Key Executives for Boston University School of Medicine
Chairman of the Department of Ophthalmology
Assistant Dean of Development
Compensation as of Fiscal Year 2015.
Boston University School of Medicine Key Developments
Amarantus Bioscience Holdings Inc Announces Research Collaboration with Boston University School of Medicine
Jan 30 14
Amarantus Bioscience Holdings Inc. announced the launch of research collaboration with Boston University School of Medicine (BUSM). In partnership with BUSM Professor of Neurology and Neurosurgery Dr. Robert Stern, the company will evaluate the feasibility of using the LymPro Test as a blood based test to identify patients early in the disease process of the neurodegenerative diseases, chronic traumatic encephalopathy and Alzheimer's disease. Dr. Stern, who is the clinical core director at the BU Alzheimer's Disease Center, has received funding from the National Institutes of Health for developing methods of detecting and diagnosing CTE during life. Under the research study, Stern and his colleagues have already examined over 70 former NFL players and 20 same age elite non-contact sport athletes.
Boston University School of Medicine and Boston Medical Center Announces Appointment of David McAneny, MD as Vice Chair of the Department of Surgery
Sep 11 13
David McAneny, MD has been named vice chair of the department of surgery at Boston University School of Medicine and Boston Medical Center. In this role, he will serve as division chief of general surgery and section chief of surgical oncology. McAneny has devoted his career to surgical oncology, endocrine and general surgery, specializing in gastrointestinal (GI) surgery. His surgical expertise is in tumors and other diseases of the endocrine organs, GI tract, pancreas, hepatobiliary system and spleen. He is experienced in laparoscopic surgery for gallbladder disease, splenectomy, adrenalectomy, bowel resection, gastroesophageal diseases and tumor staging.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries